A.C. Braud

988 total citations
23 papers, 739 citations indexed

About

A.C. Braud is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A.C. Braud has authored 23 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A.C. Braud's work include Breast Cancer Treatment Studies (8 papers), Cancer Treatment and Pharmacology (7 papers) and Colorectal Cancer Treatments and Studies (4 papers). A.C. Braud is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Cancer Treatment and Pharmacology (7 papers) and Colorectal Cancer Treatments and Studies (4 papers). A.C. Braud collaborates with scholars based in France, Belgium and United States. A.C. Braud's co-authors include Marc Buyse, Stefan Michiels, M. O’Connell, Jean‐Pierre Pignon, P. Thirion, Robert W. Carlson, Penny Sargent, Gilles Houvenaeghel, Claire Julian‐Reynier and Agnès Tallet and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

A.C. Braud

20 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.C. Braud France 13 483 198 192 167 131 23 739
Jason W. Denbo United States 17 581 1.2× 412 2.1× 390 2.0× 126 0.8× 87 0.7× 61 823
Christine Rebischung France 16 570 1.2× 362 1.8× 416 2.2× 70 0.4× 107 0.8× 34 935
Mark S. Carey Canada 22 305 0.6× 278 1.4× 138 0.7× 90 0.5× 162 1.2× 46 1.4k
Maria Ignez Braghiroli Brazil 14 583 1.2× 230 1.2× 302 1.6× 147 0.9× 43 0.3× 58 901
Wen Hsin Koo Singapore 12 275 0.6× 153 0.8× 78 0.4× 109 0.7× 217 1.7× 29 896
Aytuğ Üner Türkiye 15 400 0.8× 182 0.9× 189 1.0× 105 0.6× 53 0.4× 70 786
Marianne Davies United States 14 482 1.0× 75 0.4× 138 0.7× 46 0.3× 77 0.6× 38 795
Lieke H. J. Simkens Netherlands 12 376 0.8× 188 0.9× 135 0.7× 103 0.6× 74 0.6× 24 655
Yukiya Narita Japan 14 374 0.8× 171 0.9× 363 1.9× 43 0.3× 28 0.2× 98 732
Işıl Somali Türkiye 17 468 1.0× 91 0.5× 215 1.1× 157 0.9× 46 0.4× 51 716

Countries citing papers authored by A.C. Braud

Since Specialization
Citations

This map shows the geographic impact of A.C. Braud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.C. Braud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.C. Braud more than expected).

Fields of papers citing papers by A.C. Braud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.C. Braud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.C. Braud. The network helps show where A.C. Braud may publish in the future.

Co-authorship network of co-authors of A.C. Braud

This figure shows the co-authorship network connecting the top 25 collaborators of A.C. Braud. A scholar is included among the top collaborators of A.C. Braud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.C. Braud. A.C. Braud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hannoun‐Lévi, Jean‐Michel, H. Marsiglia, Yazid Belkacémi, et al.. (2009). Accelerated and Partial Breast Irradiation in Elderly Women: Gerico-03 Phase II Trial Results. International Journal of Radiation Oncology*Biology*Physics. 75(3). S222–S222. 2 indexed citations
2.
Marsiglia, H., Yazid Belkacémi, D. Peiffert, et al.. (2009). O7 Feasibility, reproducibility and impact on functional autonomy of a post-operative accelerated and partial breast irradiation in elderly women: GERICO-03 Phase II Trial results. Critical Reviews in Oncology/Hematology. 72(1). S16–S17.
3.
Rétornaz, F., et al.. (2007). Comparison of the Health and Functional Status Between Older Inpatients With and Without Cancer Admitted to a Geriatric/Internal Medicine Unit. The Journals of Gerontology Series A. 62(8). 917–922. 31 indexed citations
4.
Gonçalves, A., A.C. Braud, F. Viret, et al.. (2005). High-dose alkylating agents with autologous hematopoietic stem cell support and trastuzumab in ERBB2 overexpressing metastatic breast cancer: a feasibility study.. PubMed. 25(1B). 663–7. 10 indexed citations
5.
Freyer, Gilles, A.C. Braud, Pascal Chaı̈bi, et al.. (2005). Dealing with metastatic breast cancer in elderly women: results from a French study on a large cohort carried out by the ‘Observatory on Elderly Patients’. Annals of Oncology. 17(2). 211–216. 53 indexed citations
6.
Thirion, P., Stefan Michiels, Jean‐Pierre Pignon, et al.. (2004). Modulation of Fluorouracil by Leucovorin in Patients With Advanced Colorectal Cancer: An Updated Meta-Analysis. Journal of Clinical Oncology. 22(18). 3766–3775. 304 indexed citations
7.
Houvenaeghel, Gilles, Philippe Rouanet, S Arnaud, et al.. (2004). Determinants of Patients? Choice of Reconstruction with Mastectomy for Primary Breast Cancer. Annals of Surgical Oncology. 11(8). 762–771. 93 indexed citations
8.
Braud, A.C., et al.. (2004). La chimiothérapie orale est-elle une alternative au traitement du cancer chez le patient âgé ?. Pathologie Biologie. 53(1). 52–54. 1 indexed citations
9.
Arnaud, Sophie, Gilles Houvenaeghel, Vincent Moutardier, et al.. (2004). Patients' and surgeons' perspectives on axillary surgery for breast cancer. European Journal of Surgical Oncology. 30(7). 735–743. 26 indexed citations
10.
Bertucci, François, Carole Tarpin, Emmanuelle Charafe‐Jauffret, et al.. (2004). Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment. Bone Marrow Transplantation. 33(9). 913–920. 23 indexed citations
12.
Blay, Jean‐Yves, P. Berthaud, David Pérol, et al.. (2004). Continuous vs intermittent imatinib treatment in advanced GIST after one year: A prospective randomized phase III trial of the French Sarcoma Group. Journal of Clinical Oncology. 22(14_suppl). 9006–9006. 22 indexed citations
13.
Viret, F., Marc Ychou, A. Gonçalves, et al.. (2003). Docetaxel and Radiotherapy and Pancreatic Cancer. Pancreas. 27(3). 214–219. 15 indexed citations
15.
Viret, F., Christian Chabannon, Danielle Sainty, et al.. (2003). Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy. Bone Marrow Transplantation. 32(11). 1059–1064. 7 indexed citations
16.
Gonçalvès, Anthony, A.C. Braud, F. Viret, et al.. (2003). Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors.. PubMed. 23(4). 3543–8. 23 indexed citations
17.
Braud, A.C., E. Lévy, F Feuilhade, et al.. (2002). Combination of Vinorelbine, Epirubicin, and Cyclophosphamide as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer. American Journal of Clinical Oncology. 25(3). 303–307. 5 indexed citations
19.
Braud, A.C., Bernard Asselain, Suzy Scholl, et al.. (1999). Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?. European Journal of Cancer. 35(3). 392–397. 13 indexed citations
20.
Braud, A.C., et al.. (1999). Cowden disease and Lhermitte Duclos disease, markers of breast carcinoma: Report of two patients. Annals of Oncology. 10(10). 1241–1243. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026